COMPANY
GeneCentric Therapeutics
We are advancing the platform through strategic collaborations with diagnostics, pharmaceutical and biotechnology partners. We work with biopharma, diagnostics, technology, and CRO partners to enable this. From company website Source · Oct 13, 2026
Raises and deals from press releases
- Raise Series C · $8M · announced Jun 18, 2025 Company release ↗
Source quote
- Jun 18, 2025 · Company release ↗
“– GeneCentric Therapeutics, a company making precision medicine more precise through gene expression, today announced the initial closing of an $8.0 million Series C financing”
- Jun 18, 2025 · Company release ↗